|
28.5.2021 |
MT |
Il-Ġurnal Uffiċjali tal-Unjoni Ewropea |
C 204/1 |
Sommarju ta’ deċiżjonijiet tal-Unjoni Ewropea dwar l-awtorizzazzjonijiet għat-tqegħid fis-suq tal-prodotti mediċinali mill-1 ta’ April 2021 sat-30 ta’ April 2021
(Ippubblikat skont l-Artikolu 13 jew l-Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill (1))
(2021/C 204/01)
— Ħruġ ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
INN (Denominazzjoni Internazzjonali Komuni) |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Forma farmaċewtika |
Kodiċi ATC (Kodiċi Anatomiku Terapewtiku Kimiku) |
Data ta’ notifika |
||
|
21.4.2021 |
Abevmy |
bevacizumab |
|
EU/1/20/1515 |
Konċentrat għal soluzzjoni għal infużjoni |
L01XC07 |
22.4.2021 |
||
|
21.4.2021 |
JEMPERLI |
dostarlimab |
|
EU/1/21/1538 |
Konċentrat għal soluzzjoni għal infużjoni |
L01XC40 |
22.4.2021 |
||
|
21.4.2021 |
Lextemy |
bevacizumab |
|
EU/1/20/1516 |
Konċentrat għal soluzzjoni għal infużjoni |
L01XC07 |
22.4.2021 |
||
|
26.4.2021 |
Abiraterone Accord |
abiraterone acetate |
|
EU/1/20/1512 |
Pillola Pillola miksija b’rita |
L02BX03 |
30.4.2021 |
||
|
30.4.2021 |
Orladeyo |
berotralstatas |
|
EU/1/21/1544 |
Kapsula, iebsa |
B06AC |
4.5.2021 |
||
|
30.4.2021 |
Sibnayal |
ċitrat tal-potassju/karbonat idroġenat tal-potassju |
|
EU/1/20/1517 |
Biċċa żgħira li terħi l-mediċina bil-mod |
A12BA30 |
3.5.2021 |
— Modifika ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta’ notifika |
||
|
7.4.2021 |
Effentora |
|
EU/1/08/441 |
8.4.2021 |
||
|
7.4.2021 |
Instanyl |
|
EU/1/09/531 |
8.4.2021 |
||
|
7.4.2021 |
Trimbow |
|
EU/1/17/1208 |
8.4.2021 |
||
|
8.4.2021 |
Vaxzevria |
|
EU/1/21/1529 |
8.4.2021 |
||
|
13.4.2021 |
Aerinaze |
|
EU/1/07/399 |
16.4.2021 |
||
|
13.4.2021 |
Deltyba |
|
EU/1/13/875 |
14.4.2021 |
||
|
13.4.2021 |
Neoclarityn |
|
EU/1/00/161 |
22.4.2021 |
||
|
13.4.2021 |
OPDIVO |
|
EU/1/15/1014 |
14.4.2021 |
||
|
13.4.2021 |
Orgalutran |
|
EU/1/00/130 |
16.4.2021 |
||
|
13.4.2021 |
Vantavo |
|
EU/1/09/572 |
16.4.2021 |
||
|
14.4.2021 |
Comirnaty |
|
EU/1/20/1528 |
14.4.2021 |
||
|
15.4.2021 |
Natpar |
|
EU/1/15/1078 |
16.4.2021 |
||
|
15.4.2021 |
Sarclisa |
|
EU/1/20/1435 |
16.4.2021 |
||
|
15.4.2021 |
Xromi |
|
EU/1/19/1366 |
16.4.2021 |
||
|
16.4.2021 |
Cholestagel |
|
EU/1/03/268 |
27.4.2021 |
||
|
16.4.2021 |
Dynastat |
|
EU/1/02/209 |
19.4.2021 |
||
|
16.4.2021 |
Entecavir Mylan |
|
EU/1/17/1227 |
26.4.2021 |
||
|
16.4.2021 |
Epidyolex |
|
EU/1/19/1389 |
20.4.2021 |
||
|
16.4.2021 |
EVOTAZ |
|
EU/1/15/1025 |
19.4.2021 |
||
|
16.4.2021 |
Imvanex |
|
EU/1/13/855 |
27.4.2021 |
||
|
16.4.2021 |
Kyprolis |
|
EU/1/15/1060 |
20.4.2021 |
||
|
16.4.2021 |
Macimorelin Consilient Health |
|
EU/1/18/1337 |
26.4.2021 |
||
|
16.4.2021 |
Maviret |
|
EU/1/17/1213 |
20.4.2021 |
||
|
16.4.2021 |
Pegasys |
|
EU/1/02/221 |
26.4.2021 |
||
|
16.4.2021 |
Pelgraz |
|
EU/1/18/1313 |
20.4.2021 |
||
|
16.4.2021 |
Pemetrexed Lilly |
|
EU/1/15/1034 |
19.4.2021 |
||
|
16.4.2021 |
SANCUSO |
|
EU/1/12/766 |
26.4.2021 |
||
|
16.4.2021 |
Taxotere |
|
EU/1/95/002 |
29.4.2021 |
||
|
16.4.2021 |
Xaluprine |
|
EU/1/11/727 |
19.4.2021 |
||
|
16.4.2021 |
Xerava |
|
EU/1/18/1312 |
19.4.2021 |
||
|
21.4.2021 |
Adrovance |
|
EU/1/06/364 |
26.4.2021 |
||
|
21.4.2021 |
Avamys |
|
EU/1/07/434 |
28.4.2021 |
||
|
21.4.2021 |
CABOMETYX |
|
EU/1/16/1136 |
22.4.2021 |
||
|
21.4.2021 |
Fosavance |
|
EU/1/05/310 |
26.4.2021 |
||
|
21.4.2021 |
Fycompa |
|
EU/1/12/776 |
22.4.2021 |
||
|
21.4.2021 |
INCRELEX |
|
EU/1/07/402 |
22.4.2021 |
||
|
21.4.2021 |
Insulin aspart Sanofi |
|
EU/1/20/1447 |
22.4.2021 |
||
|
21.4.2021 |
Lyumjev |
|
EU/1/20/1422 |
22.4.2021 |
||
|
21.4.2021 |
Macimorelin Consilient Health |
|
EU/1/18/1337 |
23.4.2021 |
||
|
21.4.2021 |
Mvasi |
|
EU/1/17/1246 |
26.2.2021 |
||
|
21.4.2021 |
Mvasi |
|
EU/1/17/1246 |
22.4.2021 |
||
|
21.4.2021 |
NUBEQA |
|
EU/1/20/1432 |
22.4.2021 |
||
|
21.4.2021 |
Ontruzant |
|
EU/1/17/1241 |
23.4.2021 |
||
|
21.4.2021 |
OPDIVO |
|
EU/1/15/1014 |
26.4.2021 |
||
|
21.4.2021 |
Oslif Breezhaler |
|
EU/1/09/586 |
22.4.2021 |
||
|
21.4.2021 |
Pemetrexed Fresenius Kabi |
|
EU/1/16/1115 |
23.4.2021 |
||
|
21.4.2021 |
Qtern |
|
EU/1/16/1108 |
22.4.2021 |
||
|
21.4.2021 |
Ritonavir Mylan |
|
EU/1/17/1242 |
23.4.2021 |
||
|
21.4.2021 |
RoActemra |
|
EU/1/08/492 |
23.4.2021 |
||
|
21.4.2021 |
Slenyto |
|
EU/1/18/1318 |
28.4.2021 |
||
|
21.4.2021 |
Stocrin |
|
EU/1/99/111 |
26.4.2021 |
||
|
21.4.2021 |
Tegsedi |
|
EU/1/18/1296 |
22.4.2021 |
||
|
21.4.2021 |
Trogarzo |
|
EU/1/19/1359 |
26.4.2021 |
||
|
21.4.2021 |
Valdoxan |
|
EU/1/08/499 |
22.4.2021 |
||
|
21.4.2021 |
Vosevi |
|
EU/1/17/1223 |
22.4.2021 |
||
|
22.4.2021 |
COVID-19 Vaccine Janssen |
|
EU/1/20/1525 |
22.4.2021 |
||
|
26.4.2021 |
Aerius |
|
EU/1/00/160 |
30.4.2021 |
||
|
26.4.2021 |
Atazanavir Mylan |
|
EU/1/16/1091 |
27.4.2021 |
||
|
26.4.2021 |
Kaftrio |
|
EU/1/20/1468 |
5.5.2021 |
||
|
26.4.2021 |
Kalydeco |
|
EU/1/12/782 |
5.5.2021 |
||
|
26.4.2021 |
Levetiracetam Hospira |
|
EU/1/13/889 |
28.4.2021 |
||
|
26.4.2021 |
Saxenda |
|
EU/1/15/992 |
5.5.2021 |
||
|
28.4.2021 |
Bortezomib Hospira |
|
EU/1/16/1114 |
29.4.2021 |
||
|
30.4.2021 |
Benlysta |
|
EU/1/11/700 |
4.5.2021 |
||
|
30.4.2021 |
Cervarix |
|
EU/1/07/419 |
4.5.2021 |
||
|
30.4.2021 |
Dasselta |
|
EU/1/11/739 |
4.5.2021 |
||
|
30.4.2021 |
Desloratadine Teva |
|
EU/1/11/732 |
3.5.2021 |
||
|
30.4.2021 |
Jardiance |
|
EU/1/14/930 |
4.5.2021 |
||
|
30.4.2021 |
Kigabeq |
|
EU/1/18/1302 |
4.5.2021 |
||
|
30.4.2021 |
Mylotarg |
|
EU/1/18/1277 |
4.5.2021 |
||
|
30.4.2021 |
NULOJIX |
|
EU/1/11/694 |
4.5.2021 |
||
|
30.4.2021 |
Remsima |
|
EU/1/13/853 |
3.5.2021 |
||
|
30.4.2021 |
Sprycel |
|
EU/1/06/363 |
4.5.2021 |
||
|
30.4.2021 |
Strimvelis |
|
EU/1/16/1097 |
4.5.2021 |
||
|
30.4.2021 |
Tecentriq |
|
EU/1/17/1220 |
3.5.2021 |
||
|
30.4.2021 |
Xtandi |
|
EU/1/13/846 |
3.5.2021 |
— Irtirar ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill)
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta’ notifika |
||
|
21.4.2021 |
PegIntron |
|
EU/1/00/131 |
26.4.2021 |
— Ħruġ ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
INN (Denominazzjoni Internazzjonali Komuni) |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Forma farmaċewtika |
Kodiċi ATC (Kodiċi Anatomiku Terapewtiku Kimiku) |
Data ta’ notifika |
||
|
14.4.2021 |
Credelio Plus |
lotilaner /milbemycin oxime |
|
EU/2/21/271 |
Pilloli li tomgħodhom |
QP54AB51 |
15.4.2021 |
||
|
20.4.2021 |
Ultifend ND IBD |
Vaċċin kontra l-mard ta’ Newcastle, mard tal-borża sinovjali infettiva u l-marda ta’ Marek. (ħajja rikombinanti) |
|
EU/2/21/272 |
Konċentrat u solvent għal suspensjoni għal injezzjoni |
Pending |
22.4.2021 |
— Modifika ta’ awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta’ notifika |
||
|
14.4.2021 |
Suprelorin |
|
EU/2/07/072 |
19.4.2021 |
||
|
20.4.2021 |
Convenia |
|
EU/2/06/059 |
27.4.2021 |
||
|
20.4.2021 |
Cortavance |
|
EU/2/06/069 |
26.4.2021 |
||
|
20.4.2021 |
Proteq West Nile |
|
EU/2/11/129 |
4.5.2021 |
||
|
20.4.2021 |
Sevohale |
|
EU/2/16/196 |
28.4.2021 |
||
|
20.4.2021 |
Zactran |
|
EU/2/08/082 |
22.4.2021 |
||
|
26.4.2021 |
Coliprotec F4/F18 |
|
EU/2/16/202 |
30.4.2021 |
||
|
26.4.2021 |
Credelio |
|
EU/2/17/206 |
28.4.2021 |
||
|
26.4.2021 |
Emdocam |
|
EU/2/11/128 |
27.4.2021 |
||
|
26.4.2021 |
Enteroporc Coli |
|
EU/2/20/268 |
28.4.2021 |
||
|
26.4.2021 |
Neptra |
|
EU/2/19/246 |
6.5.2021 |
||
|
26.4.2021 |
Stelfonta |
|
EU/2/19/248 |
27.4.2021 |
||
|
26.4.2021 |
Trocoxil |
|
EU/2/08/084 |
27.4.2021 |
Kull min jixtieq jikkonsulta r-rapport ta’ evalwazzjoni pubblika dwar il-prodotti mediċinali kkonċernati u d-deċiżjonijiet marbuta magħhom għandu jikkuntattja lil:
|
European Medicines Agency |
|
Domenico Scarlattilaan 6 |
|
1083 HS Amsterdam |
|
NETHERLANDS |